AVEO Pharmaceuticals (AVEO) Worth a Look: Stock Up 14.8%
AVEO Pharmaceuticals, Inc. AVEO was a big mover last session, as the company saw its shares rise around 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 267% in the past one-month time frame.
The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
AVEO Pharmaceuticals currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.
AVEO Pharmaceuticals, Inc. Price
AVEO Pharmaceuticals, Inc. Price | AVEO Pharmaceuticals, Inc. Quote
A better-ranked stock in the Medical - Biomedical and Genetics industry is Aimmune Therapeutics, Inc. AIMT holding a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is AVEO going up? Or down? Predict to see what others think: Up or Down
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AVEO Pharmaceuticals, Inc. (AVEO) : Free Stock Analysis Report
Aimmune Therapeutics, Inc. (AIMT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
